A
Anavex Life Sciences Corp.
AVXL · NASDAQ · Healthcare · 298M
Closing price
$1.49
-3.25% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.3×
Enterprise value / EBITDAEV/EBITDA
-0.5×
Free cash flow yieldFCF yield
-30.7%
Return on equityROE
-48.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
2.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.